Filing Flows › Cytosorbents (CTSO) › How it makes money
How Cytosorbents (CTSO) makes money
Cytosorbents (CTSO) made $9.6M of revenue in the second quarter 2026 (Q2 2026), +0.2% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $9.6M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $9.6M | +0.2% |
| Q1 2026 | $8.9M | +2% |
| Q4 2025 | $9.2M | +0.9% |
| Q3 2025 | $9.5M | +10% |
| Q2 2025 | $9.6M | +9% |
| Q1 2025 | $8.7M | -3% |
| Q4 2024 | $6.5M | -25% |
From Cytosorbents' 10-Q filed Aug 6, 2026 (on EDGAR).
Questions
How does Cytosorbents make money?
Cytosorbents (CTSO) made $9.6M of revenue in the second quarter 2026 (Q2 2026), +0.2% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.